Read news stories from our cluster below, and keep up to date by following @ActionOnSepsis on Twitter.
News
-
July 27, 2020
Research Spotlight – Diagnosing the severity of COVID-19-related sepsis
Sepsis is a complex disease. Previously, Dr Bob Hancock and his team at UBC found that patients suffering from sepsis can be grouped into 5 distinct endotypes.
-
July 16, 2020
Le COVID-19 peut-il causer une septicémie?
Le 7 avril 2020, le Global Sepsis Alliance a fait une mise à jour sur la relation entre la COVID-19 et la septicémie.
-
July 16, 2020
Can COVID-19 Cause Sepsis?
On April 7, 2020, the Global Sepsis Alliance provided an update on the relationship between COVID-19 and sepsis.
-
July 2, 2020
Welcome to our newly established Patient Council!
We are excited to introduce the newest members of the cluster and founding members of the newly established Action on Sepsis Patient Advisory Council members:
-
-
May 4, 2020
Publication Spotlight - Generating Randomized Trial Evidence to Optimize Treatment in the COVID-19 Pandemic.
In April, Dr Srinivas Murthy and collaborators from McGill University and the University of Toronto publihsed a commentary in CMAJ discussing the importance of collaborative, randomized controlled trials for evaluating treatments for COVID-19, and outlining Canada
-
April 16, 2020
Publication Spotlight - Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature.
Many Action on Sepsis members are using their expertise in critical care, infectious diseases, diagnostics, and vaccine development to contribute to the global efforts to understand and reduce the impact of the COVID-19 pandemic.
-
April 3, 2020
UBC Medical Student Session: Learning From Sepsis Survivors
On March 9, medical students at the University of British Columbia had a unique opportunity to learn about sepsis.
-
-
March 27, 2020
Action on Sepsis researchers working to reduce the impact COVID-19
In March, investigators from Action on Sepsis were collectively awarded over $2M from Canadian federal granting agencies as part of the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity.